Author

Kibum Kim

Columbia University Irving Medical Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metabolomics· 1 Assay:proteomics· 1

Frequent Co-Authors

Eugene Son· 1 shared Hee Won YangiD· 1 shared Jessica ArmandiD· 1 shared Kevin M. KalinskyiD· 1 shared Minah KimiD· 1 shared Sungsoo KimiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Eugene Son

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Therapeutic benefits of maintaining CDK4/6 inhibitors and incorporating CDK2 inhibitors beyond progression in breast cancer

Jessica Armand, Sungsoo Kim, Kibum Kim, Eugene Son, Minah Kim, Kevin M. Kalinsky, Hee Won Yang

This study shows that continuing CDK4/6 inhibitors and adding CDK2 inhibitors slows growth of drug-resistant breast cancer by delaying cell cycle progression and reducing E2F transcription.

eLife · Dec 29, 2025Peer-reviewedCancer Biology